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326Objective:We sought to evaluate the feasibility and efficacy of a new type of video-assisted minimally invasive
surgery for patients with atrial fibrillation.
Methods: Between December 2006 and February 2008, 81 patients with lone atrial fibrillation (49 with parox-
ysmal, 17 with persistent, and 15 with long-standing persistent atrial fibrillation) underwent this therapy with
a bipolar radiofrequency ablation system. The main surgical procedures included bilateral pulmonary vein antrum
isolation, obliteration of the left atrial appendage, division of the ligament of Marshall, and intraoperative elec-
trophysiologic testing.
Results: The mean operation duration was 2.5 hours. One (1.2%) case was confirmed of left atrial appendage
thrombus during the procedure. One (1.2%) patient was converted to sternotomy during the operation. Reintu-
bation occurred in 1 (1.2%) patient, and acute heart failure occurred in 1 (1.2%) patient. One (1.2%) patient died
of cerebral infarction 1 month after the operation. Follow-up was done between 3 and 19 months (mean, 12.7
 3.9 months) after the operation. At discharge, 72.5% (58/81) of all patients were in sinus rhythm (paroxysmal
atrial fibrillation, 83.7%; persistent atrial fibrillation, 64.7%; and long-standing persistent atrial fibrillation,
40.0%). At 3 months, overall 78.5% (62/79) were in sinus rhythm (paroxysmal atrial fibrillation, 85.7%; persis-
tent atrial fibrillation, 82.4%; and long-standing persistent atrial fibrillation, 46.2%). At 6 months, overall 78.5%
(62/79) were in sinus rhythm (paroxysmal atrial fibrillation, 85.7%; persistent atrial fibrillation, 70.6%; and long-
standing persistent atrial fibrillation, 61.5%). At 12 months, overall 79.6% (39/49) were in sinus rhythm (parox-
ysmal atrial fibrillation, 80.0%; persistent atrial fibrillation, 75.0%; and long-standing persistent atrial fibrillation,
66.7%). At 18 months, 88.9% (8/9) of the paroxysmal group were in sinus rhythm.
Conclusions: This minimally invasive technique proves to be safe and less traumatic and presents optimistic
early outcomes for patients with paroxysmal and persistent atrial fibrillation. It might find wider application if
more ablation lesions could be enrolled for long-standing persistent atrial fibrillation. (J Thorac Cardiovasc
Surg 2010;139:326-32)Atrial fibrillation (AF) affects proximately 10 million per-
sons in China,1 undoubtedly the largest demographic group
in the world, including 3 million plus persons with lone AF.2
As a target group, patients with lone AF receive traditional
catheter ablation, which causes endocardial trauma, fluoros-
copy, therapeutic thrombus, and a high reablation rate.
Video-assisted minimally invasive surgery is a newly devel-
oped technique for surgical treatment of AF, showing merits
of minimal invasion, high single cure rate, and low operative
risks.3 Between December 2006 and February 2008, 81
drug-resistant and symptomatic patients with lone AF re-
ceived this video-assisted minimally invasive surgery ate Atrial fibrillation Center, Anzhen Hospital, Beijing, China.
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The Journal of Thoracic and Cardiovascular Surgthe Atrial Fibrillation Centre, Beijing Anzhen Hospital. As
the largest research group in Asia, we review our early expe-
rience of clinical application of this technique and discuss
the feasibility and key results of this research.MATERIALS AND METHODS
Patient Selection
Between December 2006 and February 2008, 81 patients with lone AF
underwent the procedure. The institutional review board approved the
research protocol, and informed consent was received from all patients.
Indications for the minimally invasive therapy in this study were drug-
refractory lone AF, including paroxysmal, persistent, and long-standing
persistent AF, according to the Heart Rhythm Society/European Heart
Rhythm Association/European Cardiac Arrhythmia Society Expert Con-
sensus Statement;4 age less than 70 years; failed catheter ablation; history
of stroke or embolism; and left atrial appendage (LAA) thrombus. The
exclusive criteria were left atrial dimension of greater than 70 mm, left ven-
tricular ejection fraction of less than 30% with ultrasonic cardiographic
(UCG) evaluation, previous cardiac surgery, and severe pleural adhesions.
Among the 81 patients, 4 (4.9%) had failed catheter therapy. Patient char-
acteristics are detailed in Table 1. Preoperative AF-related histories are
listed in Table 2.ery c February 2010
TABLE 1. Preoperative data
Characteristics Results
Male/female sex 51/30
Age at operation (y) 57.6  10.0
Paroxysmal AF 49
Persistent AF 17
Long-standing persistent AF 15
NYHA class I, n (%) 70 (86.4)
NYHA class II, n (%) 11 (13.6)
LA diameter (mm) 49.7  11.4
Duration of AF (y) 5.9  4.9
AF, atrial fibrillation; NYHA, New York Heart Association; LA, left atrium.
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AF ¼ atrial fibrillation
ECG ¼ electrocardiography
GP ¼ ganglionic plexi
ICS ¼ intercostal space
IVC ¼ inferior vena cava
LAA ¼ left atrial appendage
PV ¼ pulmonary vein
RF ¼ radiofrequency
RSPV ¼ right superior pulmonary vein
SR ¼ sinus rhythm
SVC ¼ superior vena cava
TEE ¼ transesophageal echocardiography
UCG ¼ ultrasonic cardiographyPreoperative Management
Patients underwent a detailed preoperative evaluation. Baseline 12-lead
electrocardiographic (ECG) analysis, chest radiographic scanning, transtho-
racic UCG and transesophageal echocardiographic (TEE) analysis, com-
puted tomographic scanning, stress testing, or coronary angiographic
analysis were performed on admission. Meanwhile, daily respiratory exer-
cises were also recommended. All patients were required to fill out a ques-
tionnaire about their AF history, antiarrhythmia drug use, New York Heart
Association heart function, history of stroke, and so on.
Surgical Technique
We followed the technique that has been previously reported.3 This tech-
nique was demonstrated to us by Dr Randall Wolf and consists of epicardial
radiofrequency (RF) isolation of the bilateral pulmonary vein (PV) antrum,
ligation of the LAA, and electrophysiologic testing. Overall, the ablation is
performed with an Isolator Transpolar ENDO ablation clamp (AtriCure,
West Chester, Ohio) and the Wolf Lumitip Dissector (AtriCure). Two pac-
ing and sensing devices (Detect and Carelink 2090 programmer; Medtronic,
Minneapolis, Minn) are designed as a unit to perform intraoperative testing.
An EZ-45G Endostapler (Johnson and Johnson Medical, Inc, Arlington,
Tex) was used to remove the LAA.
Right-sided ablation. General anesthesia is administeredwith a dou-
ble-lumen endotracheal tube for single-lung ventilation. In some patients
electric cardioversion is attempted during anesthesia, either before or after
the left-sided procedure. The patient is placed in the left lateral decubitus po-
sition and turned 45 to 60. The first port (10 mm) is introduced in the sixth
intercostal space (ICS) approximately 1 cm anterior to the midaxillary line.
The right lung is deflated. A 10-mm 30 thoracoscope is inserted through the
port to visualize the right hemithorax. After counting ribs internally to verify
the location of the third ICS, a 5-cm right external thoracic incision at the
third ICS between the anterior and midaxillary lines is made, serving as
the working port (Figure 1).
A Medium Soft-Tissue Retractor (Cardiovations; Ethicon GmbH, Nor-
derstedt, Germany) is inserted through working port, locating the right
phrenic nerve on the pericardium. Then an opening in the pericardium 2
to 3 cm anterior and parallel to the phrenic nerve is made, exposing the heart
3 cm superior to the superior vena caval (SVC)–atrial junction. The pericar-
dium should be opened inferiorly as far as possible (to the diaphragm). Peri-
cardial stay sutures (2 to 3) are placed in the posterior cut pericardial edge
and are anchored laterally through stab sites. We then identify anatomic
structures, such as the SVC, right superior pulmonary vein (RSPV), right
inferior PV, inferior vena cava (IVC), and right pulmonary artery.The Journal of Thoracic and CaBaseline sensing and pacing of the RSPV and right inferior PV and
bifurcation of the right PV are performed, and then ganglionic plexi (GP)
activity is detected. Both PV antrum and GP detection were done before ap-
plication of RF through the clamp and after RF application.
Afterward, a pediatric Yankauer suction is applied through a working
port to begin initial dissection between the SVC and RSPV. A space from
the superior aspect of the RSPV posteriorly and a space just inferior to
the IPV and lateral to the IVC into the oblique sinus are bluntly developed.
The second Port (10 mm) is made either medially or laterally to the scope
port for Wolf Lumitip Dissector use. Then the dissector is introduced
through the port site and into the pericardial space. The dissector tip is
fed into the oblique sinus just above the IVC. The distal end of the dissector
tip is advanced posteriorly and then swept medially into position behind the
right PVs. The device is advanced superiorly in the oblique sinus to reflec-
tions at the superior edge of the SPV just under the SVC.
The dissector tip is advanced past the SPV and articulated anteriorly, as
necessary, until the tip is exposed beneath the reflection. The dissector is
teased through the reflection under direct visualization. Dissection is com-
plete when the dissector tip is clearly visible and the tip is free from tissue.
A transfer red rubber catheter is attached to the dissector tip. Then, after
disarticulating the dissector, it is slowly retracted with the red rubber cath-
eter attached, and the dissector is removed from the port site. The lower jaw
of the Isolator Transpolar ENDO ablation clamp with the red rubber catheter
is clipped. Afterward, the red rubber catheter should lead the lower jaw of
the isolator clamp into the desired dissection plane posterior to the RPVs.
The isolator clamp is advanced until the posterior tip is visible above the
RSPV. The red rubber catheter is removed from the distal end of the lower
jaw. One should ensure that the isolator jaws are clamped over the atrial cuff
as much as possible, especially inferiorly. Then repetitive ablations are
applied at most 5 times, with a 2-mm distance among each lesion moving
toward the atrial cuff. The isolator clamp is removed. The pericardial stay
sutures are removed, and the pericardium does not need to be closed on
the right side, but epicardial pacing leads are routinely placed. A 20F chest
tube is placed through one of the inferior port sites. The right lung is rein-
flated, and incisions are closed.
Left-sided ablation. The patient is repositioned in the right lateral
decubitus position and turned 45 to 60. The incisions, electrophysiologic,
dissection, and ablation procedures are performed in a fashion similar to
those for the right side besides opening the pericardium 2 to 3 cm posterior
and parallel to the phrenic nerve, and ligament of Marshall is cut off under
direct vision.
The LAA is excluded after the left PVs have been isolated. The EZ-45G
Endostapler should be introduced through one of the inferior port sites. The
LAA is gently manipulated into the stapler jaws, and the position of the cir-
cumflex coronary artery outside the stapler is verified. The stapler is closed
and fired. It is highly recommended that the staple be kept in position for 5
seconds, and then the stapler and LAA are removed. Hemostasis is verified,
and the pericardium is closed. A 20F chest tube is inserted through one of
the port holes. The left lung is inflated, and the incisions are closed in a sim-
ilar fashion (Figure 2).rdiovascular Surgery c Volume 139, Number 2 327
TABLE 2. Preoperative AF-related histories
Characteristics Results, n (%)
Hypertension 31 (38.2)
Alcoholic history 15 (18.5)
Smoking history 19 (23.5)
Stroke/arterial embolism 12 (14.8)
Diabetes 4 (4.9)
Hyperthyroid 2 (2.5%)
Catheter ablation 4 (4.9)
Permanent pacemaker implantation 2 (2.5)
Digoxin 17 (21.0)
Betaloc 48 (59.3)
Amiodarone 45 (55.6)
Aspirin 69 (85.2)
Warfarin 23 (28.4)
AF, Atrial fibrillation.
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Intraoperative electrophysiologic testing was performed, which includes
bilateral PV antrum, baseline and postisolation sensing and pacing, and GP
detection. A baseline positive sensing result (rapid and disorderly atrial
potentials) in the PV antrum area could be detected before PV isolation,
and a negative sensing result (no atrial potentials) could be detected in the
same area after ablation, which is called entrance block. A positive baseline
pacing result is defined as the atrial and ventricular capture and is obtained.
Capture is the contraction of the atrium and ventricle in response to the elec-
trical stimulus being sent from the temporary pacemaker (Oscor Pace 203H
DDD External Dual-Chamber Pacemaker; Oscor Inc, Palm Harbor, Fla).
A negative postablation pacing result means that no capture is obtained in
the same area after ablation. A combined positive baseline pacing and neg-
ative postablation pacing result is called exit block. Achieving both entrance
and exit block is regarded as a transmural lesion blocking the conduction in
the PV antrum area. Meanwhile, GP activity detection is included in the
electrophysiologic testing procedure, as in the experience ofMehall and col-
leagues,5 which is basically mapped by using a high-frequency stimulus (10
V, 800 times per second) for 5 seconds or more. A positive response was
defined as sinus bradycardia (<40 beats/min) or asystole, atrioventricular
block, or hypotension occurring ventricular asystole of the onset of high-fre-
quency stimulus.6FIGURE 1. Minimally inv
328 The Journal of Thoracic and Cardiovascular SurgPostoperative Medical Management
Amiodarone was administered to 79 (97.5%) patients at approximately
100 to 200 mg/d for 3 months after the operation and was then tapered off in
the presence of a stable sinus rhythm (SR). Meanwhile, metoprolol tartrate
(Betaloc; AstraZeneca, Inc, London, United Kingdom) was also used in
combination with amiodarone postoperatively based on average heart rate.
Postoperative anticoagulation follows the instructions found in the
American College of Cardiology/American Heart Association/European
Society of Cardiology guidelines.7 The option of the use of warfarin or as-
pirin is based on the patient’s CHADS score. Anticoagulant drug is discon-
tinued if SR is present, and then 24- or 48-hour Holter monitoring reveals
SR at 4 months. An AF/atrial flutter episode is present if it is documented
by means of ECG or Holter monitoring and lasts at least 30 seconds.4
During the follow-up period, if ECG analysis shows recurrence of AF or
atrial flutter sustained for more than 8 hours, a direct-current cardioversion
is recommended.
Follow-up
Follow-up was obtained from office visits at an outpatient building,
mailed medical records received from local hospitals, and questionnaires.
Twelve-lead ECG analysis, 24- to 48-hour Holter monitoring (for patients
in SR with ECG), and transthoracic UCG were evaluated at discharge and
1, 3, 6 and 12 months postoperatively. Free ECG examinations and free
24- to 48-hour Holter monitoring (Del Mar Reynolds Medical, Inc, Irvine,
Calif)were offered at theAtrial FibrillationCentre,BeijingAnzhenHospital.
A database for this minimally invasive procedure was set up for this study.
Statistical Analysis
Standard descriptive statistics were applied. Values are expressed as
means  standard deviations. Outcomes of rhythms were descriptively an-
alyzed at interval contacts. Meanwhile, Kaplan–Meier analysis was used for
time-related freedom fromAF in the paroxysmal AF group. All P values are
2-tailed.
RESULTS
Operative Results, Morbidity, and Mortality
Two (2.5%) patients had preoperative permanent pace-
maker implantation because of sick SR. Mean duration of
the procedure was 2.5 hours. Mean bleeding was 81 mL.
The first 10 patients did not have LAA obliteration becauseasive surgery incisions.
ery c February 2010
FIGURE 2. Lesion set of minimally invasive surgery. SVC, Superior vena cava; RSPV, right superior pulmonary vein; GPs, ganglionic plexi; RA, right
atrium; RIPV, right inferior pulmonary vein; PV, pulmonary vein; LA, left atrium; IVC, inferior vena cava; LAA, left atrial appendage; LOM, ligament of Mar-
shall; PA, pulmonary artery; LSPV, left superior pulmonary vein; LIPV, left inferior pulmonary vein; LV, left ventricle; AV, atrioventricular.
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cerebrovascular events during follow-up. Three (3.7%)
patients had LAAs removed before ablation because preop-
erative TEE and computed tomographic scanning indicated
abnormal density in the LAA. One of the 3 patients was con-
firmed to have thrombus after LAA excision, whereas the
other 2 were proved to have thickened trabeculae in the
LAA. One (1.2%) case was converted to sternotomy after
the occurrence of bleeding during right inferior PV dissec-
tion. One (1.2%) patient had acute cardiac dysfunction
caused by subendocardial infarction and recovered within
12 days. One (1.2%) patient had reintubation caused by
hypoxemia in the intensive care unit. Two (2.5%) patients
had wound exudation. One (1.2%) patient died of cerebral
infarction 1 month after the operation. Mean postoperative
hospitalization was 4.5  2.7 days. Follow-up ranged be-
tween 3 and 19 months (mean, 12.7  3.9 months). Cardio-
version was performed in 18 (22.2%) patients beforeFIGURE 3. Frequencies of electrocardiographic analysis (ECG) and Hol-
ter monitoring during follow-up.
The Journal of Thoracic and Cadischarge and during follow-up. Overall morbidity was
7.4%, and postoperative stroke rate was 1.2%.
Heart Rhythm
One patient was lost to follow-up after discharge. Eighty
patients had a total of 452 ECG examinations during fol-
low-up, a mean of 5.7 examinations per patient. Twenty-
four-hour Holter monitoring was done in 77 (96.3%)
patients, and 48-hour Holter monitoring was done in 3
(3.7%) patients (Figure 3). Ten (12.3%) patients stopped
taking amiodarone at 1 month, with 69 (85.2%) patients
stopping the drug at 3 months.
At discharge, 72.5% (58/81) of all patients were in SR
(paroxysmal AF, 83.7%; persistent AF, 64.7%; and long-
standing persistent AF, 40.0%). At 3 months, overall
78.5% (62/79) were in SR (paroxysmal AF, 85.7%; persis-
tent AF, 82.4%; and long-standing persistent AF, 46.2%).
At 6 months, overall 78.5% (62/79) were in SR (paroxysmalFIGURE 4. Overall rhythm constitution at interval contact. SR, Sinus
rhythm; AF, atrial fibrillation; AFL, atrial flutter.
rdiovascular Surgery c Volume 139, Number 2 329
FIGURE 5. Percentage of patients in sinus rhythm in 3 groups at interval
contact.
FIGURE 6. Kaplan–Meier curve demonstrating freedom from atrial fibril-
lation (AF) in patients with paroxysmal AF.
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tent AF, 61.5%). At 12 months, overall 79.6% (39/49) were
in SR (paroxysmal AF, 80.0%; persistent AF, 75.0%; and
long-standing persistent AF, 66.7%). At 18 months,
88.9% (8/9) of the paroxysmal AF group were in SR; no
patients in the persistent and long-standing persistent AF
groups reached 18 months’ duration after the operation by
the end of the research period. Rhythm constitution of 3
groups is shown in Figure 4. Restoration of SR of 3 groups
at different time intervals is shown in Figure 5.
Based on Kaplan–Meier analysis, freedom from AF in the
paroxysmal AF group was 97% at 6 months and 86% at 12
months (Figure 6).
Atrial Contractility
During follow-up, atrial contraction was detected by
means of transthoracic UCG among 58 (96.7%) of the 60
patients in SR. Considering a peak A-wave velocity of 10
cm/s as the cutoff point for effective atrial contractility,8
among these 58 patients, 98.3% (57/58) regained atrial
transport function, and only 1 patient in the long-standing
persistent AF group did not show effective left atrial func-
tion despite restoration of SR.
DISCUSSION
Surgical treatment ofAF is knownas presenting the longest
history and best outcomes.9 In recent years, with the emer-
gence of alternative ablation energy sources, the traditional
cut-and-sew technique is being replaced with ablation tech-
nology, which makes atrial lesions using these new energies
and also shows promising outcomes.10,11 However, because
of the limitation of operative approaches, currently, the
main indication of surgical ablation is still a patient with AF
with a concomitant disease that requires a cardiac operation.
Aiming at patients with lone AF, the first report of a min-
imally invasive, epicardial ablation therapy was published in
2003.12 This new off-pump, bilateral thoracoscopic PV iso-
lation technique extends the implications of surgical therapy330 The Journal of Thoracic and Cardiovascular Surgof AF. According to this study, the minimally invasive tech-
nique offers good early outcomes, particularly for AF with
a short persistent history.
First, the results show an optimistic therapeutic effect for
paroxysmal AF similar to that seen in the latest studies,5,13,14
which is closely related to the multiple complete and trans-
mural PV antrum isolation lesions that the minimally inva-
sive technique accomplishes. Electrophysiologic studies
demonstrate that the PVs and posterior left atrium are critical
anatomic sites in human patients with lone AF.15,16 During
the minimally invasive operation, the bipolar RF clamp
compresses PV antrum tissue, and energy is delivered
between the jaws together with the transmurality feedback
algorithm, and the transmurality of the isolation lesion is the-
oretically ensured. Furthermore, 3 to 4 lesions are made from
distal to proximal atrial tissue on each side, and as a result,
ectopic triggers are theoretically isolated.
In addition to the transmurality algorithm and multiple
isolation lesions, the epicardial electrophysiologic testing
also further helps to evaluate the quality of the atrial lesion.
Preablation sensing (baseline sensing) detected rapid and
disorderly atrial potentials in all patients who were in AF
during the operation. And postablation sensing shows 3 out-
comes of the potentials in the same area: disappearance
(‘‘quiet’’), regular and slow potentials as normal atrial po-
tentials in SR, and disorderly potentials but not as intensive
and rapid as before ablation. In this study reisolation ablation
will be performed if either of the latter 2 sensing potentials is
detected until a ‘‘quiet’’ sensing field is obtained. Whatery c February 2010
TABLE 3. Operative and postoperative data
Patient outcomes Results
Procedure time (h) 2.5  0.8
LAA thrombus, n (%) 3 (3.7)
Sternotomy, n (%) 1 (1.2)
Acute respiratory failure, n (%) 1 (1.2)
Acute cardiac dysfunction, n (%) 1 (1.2)
Postoperative stay (d) 4.5  2.7
Cardioversion, n (%) 14 (17.3)
Stroke, n (%) 1 (1.2)
LAA, Left atrial appendage.
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(27.2% [22/81]) persistent regular and small potentials
sensed even if ablations were done on a certain side. Often,
these diminutive potentials recorded after ablation can repre-
sent ‘‘far-field’’ left atrial potentials.17 The effect of this
‘‘positive’’ postablation sensing and GP detection results
on short-term and midterm therapeutic outcomes is under
observation in a concurrent study. As for ‘‘exit block,’’
based on the baseline preablation pacing threshold in PV an-
trum, a 5-mV stimulus intensity is added in a stepwise man-
ner to at most 20 mV for the postablation pacing. In this
study pacing results show that all patients who were in SR
after bilateral ablations did not show ‘‘atrial and ventricular
capture’’ and accordingly achieved ‘‘exit block.’’
Second, this study proves the feasibility of surgical liga-
tion of the LAA through the minimally invasive technique.
Thrombotic material associated with AF arises most fre-
quently in trabeculated portions, such as the LAA.7,18 Ac-
cording to the study of Odell and associates,19 the
thrombus was localized to the LAA in 91% of patients
with nonrheumatic AF, including patients with lone AF.
When combined with amputation or obliteration of the
LAA, postoperative thromboembolic events are substan-
tially reduced.7 This minimally invasive technique offers
a safe and easy approach to remove the LAA, even though
for the first 10 patients the LAA was not obliterated because
a right endoscopic cutter was not available, but during more
than 12 months’ follow-up, none of these patients had cere-
brovascular events.
In this research 3 patients had left thoracotomies first and
LAAs excised before ablation because results of preopera-
tive TEE and imaging indicated abnormal density in the
LAA. Even though only 1 of the 3 cases of thrombus was
confirmed afterward, our experience still demonstrates
that, unlike other studies,14 based on proper selection and
valid technique, patients with lone AF with LAA thrombus
can be treated with this minimally invasive therapy with an
adjusted operative strategy. But patients still require antico-
agulation therapy during the postoperative 4 months, even if
restoration of SR presents. The therapy can be discontinued
if Holter monitoring reveals stable SR at 4 months. During
follow-up, 1 patient in the long-standing persistent AF groupThe Journal of Thoracic and Cadied of stroke at 1 month. This patient had AF recurrence 2
weeks after the operation but stopped warfarin by himself
because gingival bleeding occurred 4 days before the stroke.
Twelve patients had a history of stroke before the operation,
and only 1 (0.83%) of them was confirmed to have LAA
thrombus, as mentioned above. All 12 patients were admin-
istrated warfarin after the procedure, and 6 of 11 (1 was lost
follow-up) were in stable SR at the latest hospital visit. Then
warfarin was replaced with aspirin.
The long-standing persistent AF group shows 44.4% and
71.4% SR restoration rates at 3 and 6 months postopera-
tively, respectively. Similar research14 also reports 67%
and 72% success rates, respectively. Based on these results
and other studies,20 bilateral PV isolation might not be
a good option for this type of AF. As for long-standing per-
sistent AF, modification of the atrial substrate plays a more
important role in the maintenance of re-entry wavelets than
ectopic initiation triggers in the PV area. Therefore more
atrial lesions are needed to break the re-entries than just iso-
lating the PV antrum region for curing long-standing persis-
tent AF. The current catheter technique has adopted a left
atrial linear ablation strategy, such as with the left atrial
roof and mitral annular lesions, for AF with a persistent his-
tory of more than 12 months.21 Through this study, we be-
lieve that the main target of the minimally invasive
technique is still paroxysmal and persistent AF. As for
long-standing persistent AF, this technique should further
include more atrial linear lesions with development of new
technology and surgical approaches, such as the extracardiac
maze procedure performed on the beating heart.22 Perhaps
a hybrid technique is more available at present, which means
supplementing endocardial left atrial ablationwith a catheter,
combined with this minimally invasive operation, to reverse
substrate modification of long-standing persistent AF and
achieve possibly better outcomes.
This minimally invasive approach demonstrates a high
degree of safety and fewer traumas. Basically, the main
influences are related to general anesthesia and surgical inci-
sions, but it still concerns patient selection and a learning
curve. In this study 1 (1.2%) patient was converted to ster-
notomy after the occurrence of bleeding during right inferior
PV dissection. Considering he was the fourth patient since
our center started this operation, based on our experience,
a learning curve of approximately 12 surgical procedures
is a realistic expectation with the technique. One (1.2%)
patient had postoperative acute respiratory failure and rein-
tubation, which was due to a long smoking history and
decrease of lung function. One (1.2%) patient had acute car-
diac dysfunction caused by subendocardial infarction in
spite of a negative preoperative coronary angiographic
scan, and after discharge, this patient has been in stable
SR according to 2 bouts of 24-hour Holter monitoring at 3
and 10 months, respectively. Despite the morbidities in
this study, the minimally invasive approach still providedrdiovascular Surgery c Volume 139, Number 2 331
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tion, this technique only applies epicardial ablation on a beat-
ing heart, without any contact with the endocardium, which
avoids the risks of thrombus formation caused by foreign
bodies, such as ablation devices and endocardial trauma.23,24
Furthermore, during the minimally invasive operation, un-
der endoscopic and direct vision, the whole ablation proce-
dure is done within the pericardial space, plus the energy
flow between the 2 jaws of the bipolar clamp, and no collat-
eral damage is observed. More importantly, the ablation is
performed in the PV antrum area, and rarely complications
of PV stenosis would occur.
This minimally invasive operation is a combination of
both endoscopic and thoracic techniques. Thoracoscopy is
used to verify the exact location of the working incision at
the third ICS, which provides excellent access to bilateral
PVs and GP and to assist visualization during the procedure.
Most of the procedure is done by the surgeon through the
small 4- to 5-cmworking incision under direct vision. There-
fore avoiding the full thoracoscopic technique significantly
reduces the complexity and shortens the learning curve
and, as a result, promotes the adaptability of this minimally
invasive operation. On the other hand, this technique
requires bilateral thoracic incisions and bilateral positioning
during the procedure. Meanwhile, with the limitation of sur-
gical access and bipolar RF clamping, bilateral PV isolation
for paroxysmal AF is still the main target of the minimally
invasive technique.
CONCLUSIONS
Video-assisted minimally invasive surgery with the bipo-
lar RF system with multiple PV antrum isolation lesions
made and guided by means of intraoperative electrophysio-
logic testing has been proved to be an effective, easy, and
safe technique for AF, particularly for patients with paroxys-
mal AF. Future studies should emphasize how to enroll
patients with long-standing persistent AF, probably by
adapting a new approach to apply a more extensive proce-
dure for optimistic therapeutic effects.
We thank Shu-ping Ding for her assistance in data collection.
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